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1. Introduction 
The surge of interest taken in the chemical study 
of the histones - the basic proteins associated with 
DNA - is partly due to the generally received opinion 
that these proteins have a major role in gene expres- 
sion. This hypothesis of gene control by histones [ 1] 
cannot yet be supported by the results of many in- 
vestigations. Recent comparative chemical studies of 
histones from various tissues [2-61 have shown a lack 
of specificity in these proteins. Moreover, no signifi- 
cant differences have been found between the compo- 
sitions of histones from tumor and normal tissues 
[5,7,81. 
However, since histone specificity has been re- 
ported in some differentiated cells as erythrocytes 
[9- II], silkgland cells [ 121, or baker’s yeast cells 
[ 131, it was tempting to determine whether the 
histones extracted from tumors induced by onco- 
genie viruses presented any feature of specificity. 
The considerable progress made in the prepara- 
tion and fractionation procedure of histones [ 14,151 
allowed us to isolate and compare the now well- 
defined five main histone fractions of three types of 
virus-induced tumor cells: cells from tumors induced 
in newborn hamsters by human adenovirus 12 [ 161, 
cells from hamster tumors induced by the hybrid 
virus human adenovirus 2 - simian virus 40 [ 17,181 
and rat embryo cells transformed in vitro by human 
adenovirus 2 [ 191 . 
The chemical study of tumor histones can contri- 
bute in some way to the understanding of the cellular 
processes involved in DNA replication and oncogene- 
sis. 
North-Holland Publishing Company A rnsterdarn 
2. Experimental procedures 
The hamster tumors and the rat transformed cells 
have been kindly supplied by Pr. J.Samaille (Depart- 
ment of Virology of the Institut Pasteur of Lille). 
2.1. Tumors 
Adenovirus 12 and Ad2-SV40-induced tumors were 
obtained by injecting subcutaneously 8- 10 day old 
hamsters with 0.1 ml of a hamster tumor cells suspen- 
sion titering 2 to 3 X lo7 cells/ml. When the tumor 
mass weighed approximately 1 to 2 g, and before 
necrosis occurred, the tumors were excised, minced, 
dispersed in a Waring-Blendor at low speed for 2 min 
in 4-5 volumes of phosphale-buffered saline, and 
filtered through three layers of gauze. The homo- 
genate was washed three times in 0.25 M sucrose 
_ 0.01 M Tris - HCl - 3.3 mM CaC12 buffer pH 7.0 and 
the tumor cells were obtained by centrifuging at 
600 X g for 10 min at 4°C. 
2.2. Transformed cells 
The continuous cell line of Adttransformed rat 
embryo cells was grown in suspension in EAGLE’s 
basal medium supplemented with 5% horse serum. 
The cells were harvested by mild centrifugation at 
600 X g for 10 min at 4”C, resuspended in 0.25 M 
sucrose --- 0.01 M Tris .- HCl - 3.3 mM CaC12 and 
successively centrifuged and washed three to four 
times in this buffer in order to eliminate all traces of 
culture medium. 
2.3. Preparation o.f nuclei 
All fractionation procedures were carried out at 4°C. 
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The cells pellets were homogenized in a Potter- 
Elvehjem homogenizer with a teflon pestle at 3,500 
rev/min for 2f min in 10--l 5 ml of the 0.25 M sucrose 
- Tris .-- HCl - CaCIZ buffer. The suspension was cen- 
trifuged at 1,000 X g for 10 min and the nuclei thus 
obtained were then washed and centrifuged three times 
in the sucrose solution. 
2.4. Preparation of nucleohistones 
The nuclear pellets were resuspended in 0.14 M 
NaCl containing 0.01 M sodium citrate pH 7.0 and one 
drop of a 1% diisopropylfluorophosphate solution 
(DFP) was added per ml of this nuclear suspension, as 
enzyme inactivator. The suspension was then homo- 
genized by using an Ultra-Turrax homogenizer succes- 
sively three times for 1 min and the homogenate 
centrifuged at 3,000 X g for 15 min. The sediment 
was washed five times with the NaCl - Na citrate buf- 
fer, without DFP. 
Izig. 1. Polyacrylamide gel electrophoresis of histones from 
Ad2-SV40-induced tumor. 1: whole histone; 2: Fl; 3: l’sCa)l; 
4: IC2(a)2; 5: 1:2b; 6: 1:3. Similar patterns were obtained with 
corresponding fractions from other tumor cells. 
2.5. Preparation of whole histone 
Whole histone was prepared by the method of 
Johns et al. [20] using 0.25 N HCI. 
2.6. Preparation of histone fractions 
from cathode to anode, to fractions F2(a) 1, the 
faster-moving band, F2(a)2, the most strongly stained 
band, F2b and F3 together as a single weakly stained 
band behind F2(a)2, and F 1, the slowest migrating 
band. 
The selective extraction of histone fractions F2(a)l 
and F2(a)2 was carried out by using a mixture of 
ethanol and guanidinium chloride at pH 7.0 [21]. 
Each of the FZ(a) subfractions was greatly contami- 
nated by the other [S] . They were therefore further 
purified by another method, using acetone precipita- 
tion at low pH value [ 141. The other histone fractions 
were removed according to the method of Johns 1221. 
3.7. Analyses 
The electrophoretic patterns of the histone fractions 
(fig. 1) show that each one is slightly contaminated by 
the others: fractionation by selective extraction and 
selective precipitation of the histones does not yeld 
pure fractions. Another step, such as gel filtration 
chromatography, is therefore necessary to purify 
them. Nevertheless, the purity of each fraction ob- 
tained by the selective extraction procedure is gen- 
erally accepted as sufficient for amino-acid analysis 
comparison. 
Purity of the fractions was checked by analytical 
disc electrophoresis in 15% acrylamide gels containing 
6.25 M urea at pH 4.3, according to a modification 
[23] of the method of Reisfeld et al. [24]. Amino- 
acid analyses were performed after 24 hr hydrolysis 
in 5.6 N HCl at 110°C under vacuum. 
3. Results and discussion 
The amino-acid compositions are presented in table 1 
The general characteristics of each fraction is preserved: 
F 1 is lysine-alanine rich, F2(a) 1 glycine-arginine rich, 
F2(a)2, F2b and F3 are arginine-lysine rich. The most 
remarkable point is that all corresponding fractions 
from the three types of tumor have the same amino 
acid composition. But some differences, notably a 
higher content of acidic amino-acid, are observed 
with whole histone and histone fractions from calf 
thymus. 
Polyacrylamide gel electrophoresis of the whole Fractions F 1 show the most significant differences 
histone from Ad2-SV40 tumor cells (fig. 1) shows a with F 1 from calf thymus and from other animal 
pattern of four bands corresponding, successively tissues, i.e. a higher content of acidic amino-acid and 
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a lower content of lysine and alanine. Such differences 
concerning glutamic and aspartic acids and lysine in 
fraction F 1 have been previously reported for histones 
from hepatopancreas of Mytilus edulis [4] . Moreover, 
as reported by Palau et al. [25], most of the nuclear 
proteins from metabolically acitve cells are more acid 
than histones from inactive cells: this is the case for 
our tumor cells. It is also interesting to note that an 
acidic contaminant of histone fraction F2a has been 
recently described [26]. A high amount of this con- 
taminant in tumor histones could perhaps explain 
the differences observed in amino-acid composition 
of whole histone and of histone fractions. 
In summary, the amino-acid compositions generally 
do not show a specificity of the histone fractions 
isolated from virus-induced tumors. However, some 
particularities concerning fraction Fl deserve further 
investigation. 
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